Pennine Acute medics receive top prizes at regional research awards

Dr Limdi
Pennine Acute medics receive top prizes at regional research awards
05 November 2014

TWO inspirational doctors from The Pennine Acute Hospitals NHS Trust have scooped two top prizes for their ground-breaking research at this year’s Greater Manchester Clinical Research Awards 2014 ceremony.

Clinical research staff from Greater Manchester hospital Trusts and GPs surgeries were celebrating excellence in health care research across 13 categories at the special annual regional awards event on Thursday 30 October.  

Pennine Acute Trust medics Professor Deepak Bhatnagar, consultant in diabetes and metabolism, received a Lifetime Achievement Award after 30 years of service bettering medical care, and Dr Jimmy Limdi, consultant gastroenterologist, won the Investigator of the Year Category.

Since research into lipids at the University of Manchester in the 1980s, Professor Bhatnagar has authored more than fifty academic papers. Dr Limdi (pictured) was awarded the Investigator of the Year prize after his Irritable Bowel Disease patients were given alternatives to radical surgery through the clinical studies he has been launching every year since 2008.

The Trust’s North Manchester Diabetes Research Team was also runner up in the Research Impact Award category.

Chief operating officer of the Clinical Research Network: Greater Manchester, Debbie Vinsun, said:

“Clinical research provides the evidence we need to improve treatments for patients, and having a strong research culture helps to create a strong health service. By providing more opportunities for patients to consider research alongside their other treatment options, we can contribute towards a healthier Greater Manchester. The research awards provide a great way to recognise and reward some of the people and teams who make health care research in our region so successful and dynamic.”

The PAHT Board recognises the strong association between high quality clinical care and levels of research activity. The Trust is actively involved in clinical research and this participation is essential to the continual quest for improvement in treatments and therapies for patients. Only by carrying out research into “what works” can the NHS continually improve treatment for patients and understand how to focus NHS resources where they will be most effective.

In 2010/11, the Trust supported NIHR CRN studies across 14 NIHR CRN speciality groups.  This figure increased to 24 different NIHR CRN speciality groups during 2013/14, which was a 71% increase. Last year, the Trust  Provided research opportunities that enabled over 2000 patients to participate in high quality research studies (NIHR CRN), which was a 40% increase on the previous year.  The Trust currently supports over 350 research studies that have received a favorable opinion from a National Research Ethics Service. Of these studies, 75 are clinical trials involving medicinal products.

For more information about the Trust’s clinical research and development, go to